Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms: HELP
Articles by Geoffrey Paul Schembri
Based on 3 articles published since 2010
(Why 3 articles?)
||||

Between 2010 and 2020, Geoffrey Paul Schembri wrote the following 3 articles about Pancreatic Neoplasms.
 
+ Citations + Abstracts
1 Article Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor. 2017

Chan, Mico / Schembri, Geoffrey Paul. ·From the Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia. ·Clin Nucl Med · Pubmed #27997429.

ABSTRACT: Metastatic neureoendocrine tumor to bone is well recognized. Typically, this has an appearance of multiple focal lesions. We present an example of diffuse skeletal involvement on both F-FDG PET/CT and Ga DOTATATE PET/CT with a pattern similar to the superscan appearance described on skeletal scintigraphy.

2 Article Serous Cystadenoma of the Pancreas Showing Uptake on 68Ga PSMA PET/CT. 2017

Chan, Mico / Schembri, Geoffrey Paul / Hsiao, Edward. ·From the Department of Nuclear Medicine, Royal North Shore Hospital, New South Wales, Australia. ·Clin Nucl Med · Pubmed #27764044.

ABSTRACT: Ga prostate-specific membrane antigen (PSMA) PET/CT is increasingly used to evaluate extent of disease in prostate carcinoma. Several other benign and malignant pathologies have also been reported to demonstrate PSMA avidity. We present a case of serous cystadenoma of the pancreas showing focal uptake on PSMA PET/CT.

3 Article Metastatic Renal Cell Carcinoma in the Thyroid Gland and Pancreas Showing Uptake on 68Ga DOTATATE PET/CT Scan. 2016

Kanthan, Gowri L / Schembri, Geoffrey Paul / Samra, Jaswinder / Roach, Paul / Hsiao, Edward. ·From the *Department of Nuclear Medicine, Royal North Shore Hospital; ‚ĆDepartment of Radiology, Prince of Wales Hospital; and ‚Ä°Department of Surgery, Royal North Shore Hospital, Sydney, Australia. ·Clin Nucl Med · Pubmed #27055137.

ABSTRACT: Ga DOTATATE PET/CT is an imaging technique used in the diagnosis of neuroendocrine tumors. We report a case of 66-year-old woman with a history of surgically removed renal cell carcinoma who presented for a DOTATATE PET/CT scan to characterize a newly diagnosed pancreatic lesion. DOTATATE-avid lesions were identified in the thyroid gland and pancreas. Subsequent biopsy confirmed the diagnosis of metastatic renal cell carcinoma at both sites. It is important to be aware that tumors other than neuroendocrine tumors may also show uptake on DOTATATE PET/CT scan. A biopsy may be required if lesions are identified at atypical sites.